logo BDSP

Base documentaire


  1. The pharmacoeconomics of clozapine : a review.

    Article, Communication - En anglais

    Clozapine : 1994. Symposium. Garden City NY USA, 1994/02/25.

    Background 

    A pharmacoeconomic analysis of clozapine is of particular importance because clozapine has a unique profile of benefits, risks, and costs relative to typical neuroleptic drugs and because it is currently approved for use in only two populations, i.e., neuroleptic-resistant and neuroleptic-intolerant schizophrenic patients, although it has also been found to be useful in a variety of other indications, e.g.. refractory bipolar patients.

    Method 

    The three studies of the primary data relevant to a pharmacoeconomic analysis of clozapine in the treatment of schizophrenia were reviewed.

    Mots-clés Pascal : Clozapine, Neuroleptique, Psychotrope, Chimiothérapie, Traitement, Analyse coût, Economie santé, Prévention, Hospitalisation, Homme

    Mots-clés Pascal anglais : Neuroleptic, Psychotropic, Chemotherapy, Treatment, Cost analysis, Health economy, Prevention, Hospitalization, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0019831

    Code Inist : 002B02B03. Création : 09/06/1995.